Bioinformatics Services Market Size, Trends, Growth, Opportunities (2023-2030) | Illumina, Inc., QIAGEN, Thermo Fisher Scientific Inc., and Eurofin Scientific

The Bioinformatics Services Market was valued at USD 4.32 billion in 2023 and is projected to grow from USD 5.34 billion in 2024 to USD 18.13 billion by 2032, recording a CAGR of 16.5% during the forecast period (2023-2030).

The Bioinformatics Services Market continues to expand as the demand for data-driven approaches in genomics and proteomics intensifies. With advancements in sequencing technologies and computational tools, bioinformatics has become integral to personalized medicine, drug discovery, and biological research. This article explores key industry developments, leading market players, and growth opportunities shaping the future of this dynamic market.

𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂'𝗿𝗲 𝗠𝗶𝘀𝘀𝗶𝗻𝗴: 𝗚𝗲𝘁 𝗮 𝗙𝗿𝗲𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 (𝗣𝗗𝗙) 𝗦𝗮𝗺𝗽𝗹𝗲: https://www.fortunebusinessinsights.com/enquiry/sample/bioinformatics-services-market-109496

𝗞𝗲𝘆 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁

In June 2023, Psomagen unveiled its adoption of the Pacific Bioscience Revio system. This cutting-edge sequencing platform supports services such as whole genome sequencing, whole exome sequencing, single-cell and bulk RNAseq, microbiome analysis, and Olink Proteomics. The addition of the Revio system enhances Psomagen's capability to deliver precise and comprehensive bioinformatics solutions, marking a significant milestone in the field.

𝗧𝗼𝗽 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗕𝗶𝗼𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗰𝘀 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁

• Illumina, Inc. (U.S.)
• QIAGEN (Netherlands)
• CD Genomics (U.S.)
• Excelra (U.S.)
• Creative Proteomics (U.S.)
• Fios Genomics (U.K.)
• Thermo Fisher Scientific Inc. (U.S.)
• Eurofins Scientific (Luxembourg)
• Psomagen (U.S.)

𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀 𝗮𝗻𝗱 𝗥𝗲𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀

𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀

• Rising demand for genomics and proteomics in precision medicine and drug development.
• Technological advancements in sequencing platforms and bioinformatics tools.
• Increasing adoption of big data analytics and AI in biological research.
• Expanding government and private funding for genomics research initiatives.
• Growth in personalized medicine and biomarker discovery applications.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀

• High costs associated with advanced sequencing platforms and bioinformatics services.
• Complexity in managing and interpreting large datasets.
• Lack of skilled professionals to operate and analyze bioinformatics tools in developing regions.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝘃𝗲𝗿𝗮𝗴𝗲

The market report provides detailed insights into the bioinformatics services industry, covering emerging trends, competitive landscapes, and segmentation by service type. It also highlights innovations in genomics, proteomics, and sequencing technologies driving market growth.

𝗙𝗼𝗿 𝗙𝘂𝗹𝗹 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝘃𝗲𝗿𝗮𝗴𝗲 𝗩𝗶𝘀𝗶𝘁: https://www.fortunebusinessinsights.com/bioinformatics-services-market-109496

𝗠𝗮𝗿𝗸𝗲𝘁 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲

Companies like Illumina, QIAGEN, and Thermo Fisher Scientific are at the forefront of the bioinformatics services market, leveraging cutting-edge technologies to deliver comprehensive solutions. Their strategic initiatives, including partnerships, product launches, and R&D investments, contribute to a highly competitive and innovative landscape.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀

By service type, the sequencing segment led the market in 2023, driven by increasing demand for high-throughput sequencing technologies such as next-generation sequencing (NGS). Applications like whole genome sequencing, RNAseq, and microbiome analysis continue to dominate, underscoring the significance of sequencing services in bioinformatics.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀

The bioinformatics services market exhibits significant growth potential across different regions:

• North America: Dominates the market due to advanced healthcare infrastructure, substantial R&D investments, and high adoption of sequencing technologies.
• Europe: Experiences robust growth driven by government funding for genomics research and expanding biotech industries.
• Asia-Pacific: Emerges as a lucrative market due to increasing genomics research activities and the presence of key players in countries like China and India.

𝗙𝘂𝘁𝘂𝗿𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗰𝗼𝗽𝗲

• Development of AI-integrated bioinformatics tools for faster data analysis and interpretation.
• Expansion of cloud-based bioinformatics platforms for enhanced accessibility and scalability.
• Growth in multi-omics research combining genomics, proteomics, and metabolomics.
• Increased adoption of bioinformatics in agricultural and environmental studies.
• Collaboration between bioinformatics companies and pharmaceutical firms for drug discovery advancements.

𝗖𝗼𝗻𝗰𝗹𝘂𝘀𝗶𝗼𝗻

The Bioinformatics Services Market is poised for substantial growth, driven by technological advancements, increasing demand for personalized medicine, and expanding applications in genomics and proteomics. Key players like Illumina and Psomagen continue to innovate, ensuring the market remains dynamic and competitive. With opportunities in AI integration, multi-omics, and cloud-based solutions, the bioinformatics services market promises a transformative future in biological research and healthcare.

For detailed insights, visit the Bioinformatics Services Market Report.

𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗔𝗰𝗰𝗼𝗿𝗱𝗶𝗻𝗴 𝗧𝗼 𝗬𝗼𝘂𝗿 𝗖𝗼𝗻𝘃𝗲𝗻𝗶𝗲𝗻𝗰𝗲: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/bioinformatics-services-market-109496

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝘀:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.:+1 833 909 2966 (Toll-Free)
U.K.: +44 808 502 0280 (Toll-Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.